Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be an administrative metadata update.
    Difference
    0.1%
    Check dated 2026-03-19T23:44:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-12T20:08:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-03-05T18:24:16.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page; content remains unchanged.
    Difference
    0.1%
    Check dated 2026-02-26T13:41:44.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The changes appear to be a UI/layout update to the study page, with no alterations to core content such as the study overview, eligibility criteria, outcomes, or locations. No data or study information appears to be modified.
    Difference
    0.1%
    Check dated 2026-02-19T04:55:56.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2 and 'Bile duct cancer' was added as a related topic. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-12T01:50:19.000Z thumbnail image

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.